title: Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
authors.affiliation: Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Australia.
authors.forename: B G
authors.initials: BG
authors.lastname: Stuckey
authors.forename: D H
authors.initials: DH
authors.lastname: Gutteridge
authors.forename: G O
authors.initials: GO
authors.lastname: Stewart
authors.forename: R L
authors.initials: RL
authors.lastname: Prince
authors.forename: L C
authors.initials: LC
authors.lastname: Ward
authors.forename: G N
authors.initials: GN
authors.lastname: Kent
authors.forename: R I
authors.initials: RI
authors.lastname: Prince
authors.forename: R W
authors.initials: RW
authors.lastname: Retallack
authors.forename: C I
authors.initials: CI
authors.lastname: Bhagat
authors.forename: G C
authors.initials: GC
authors.lastname: Nicholson
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood; D004164:Diphosphonates / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007262:Infusions, Intravenous; D010001:Osteitis Deformans / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000652:urine; D010147:Pain Measurement; D000077268:Pamidronate; D011859:Radiography; D012720:Severity of Illness Index
chemical_list: D004164:Diphosphonates; D000469:Alkaline Phosphatase; D000077268:Pamidronate; D006909:Hydroxyproline